The biologic safety of the Cochlear Corporation multiple-electrode intracochlear implant.
Studies have been undertaken to confirm the biologic safety of the Cochlear Corporation multi-electrode intracochlear implant. The materials used are biocompatible. The electrode array is flexible: it can be inserted with minimal or no trauma, providing the insertion is stopped when resistance is first felt. An atraumatic insertion is facilitated if a good view is obtained along the scala tympani of the basal turn of the cochlea by drilling through the crista fenestrae. The passage of the electrode around the cochlea can be facilitated if the electrode is rotated during insertion (clockwise for the left and anticlockwise for the right cochlea). The electrode can be explanted and another one reinserted with minimal or no trauma. A seal established around the electrode after an implantation period of 2 weeks can prevent infection extending from the middle to the inner ear. The electrical stimulus parameters produced by the Nucleus receiver-stimulator cause no loss of spiral ganglion cells or corrosion of the platinum band electrodes. Long-term stimulation has been carried out for up to 8 years in patients without affecting their clinical performance.
Webb
R L
RL
Department of Otolaryngology, University of Melbourne, Victoria, Australia.
Clark
G M
GM
Shepherd
R K
RK
Franz
B K
BK
Pyman
B C
BC
D000818:Animals; D002415:Cats; D003054:Cochlear Implants / Q000009:adverse effects*; D004558:Electric Stimulation / Q000009:adverse effects; D006801:Humans; D008422:Materials Testing; D010033:Otitis Media / Q000209:etiology; D013701:Temporal Bone / Q000293:injuries*